Does androgen deprivation therapy help with difficulty passing urine?

Androgen deprivation therapy, also called hormone therapy or ADT, lowers the effect of male sex hormones that can support prostate cancer growth. If the prostate or cancer-related tissue is narrowing the channel that carries urine, reducing cancer activity may gradually reduce pressure and improve flow. ADT does not open a blocked urethra directly, and difficulty passing urine can also have causes unrelated to cancer, such as benign prostate enlargement, infection, medicines, or a bladder problem.

Your clinician may assess your symptoms, examine you, and check how well your bladder is emptying. The plan may include a urinary catheter, a medicine to relax the prostate outlet, radiation, surgery, or another cancer treatment, depending on the cause and your overall treatment plan.

Tell your oncology or urology team when the problem began, whether the stream is weak or intermittent, and whether you have pain, fever, blood in the urine, or a feeling of incomplete emptying. Do not stop or delay ADT without medical advice. Keep taking medicines exactly as prescribed, and ask whether a bladder scan or other assessment is appropriate. A symptom record can help your team compare changes after treatment begins.

Seek urgent medical care if you cannot pass urine, have severe lower abdominal pain or swelling, become confused or very unwell, or develop fever with painful urination. These signs can indicate acute urinary retention or infection and need prompt assessment. Contact your treatment team promptly for worsening flow, new blood in the urine, flank pain, or repeated nighttime urination, even if you can still pass urine.

Ask what is causing the urinary difficulty, whether ADT is expected to help in your situation, how quickly a change might be noticed, and which symptoms should trigger same-day help. You can also ask whether another treatment is needed to protect bladder function while cancer treatment takes effect.